Menu Global Oral Anticoagulation Shortness of Breath VTE Cardiometabolic Services GI Parasites HIV Legionnaire's Disease Influenza (Flu) Malaria Measles Mononucleosis MRSA Mumps Pneumonia RSV Rubella S. aureus Strep A pharyngitis Streptococcus pneumoniae Syphilis C-reactive Protein Toxoplasmosis Tuberculosis Varicella Zoster Other Infectious Disease Alere i Alere Influenza A & B Test Alere INRatio 2 Alere NMP22 Alere PBP2a Alere Pima CD4 Alere q Alere TestPack Alere Toxicology Alere Triage Clearview epoc NycoCard TECHLAB Additional Brands Clearview epoc SD BiOLINE TECHLAB Facebook Twitter Linkedin YouTube Alere™ Reader Rapid, Objective, Accurate. The Alere™ Reader accurately reads and interprets your Alere BinaxNOW® Streptococcus pneumoniae and Legionella lateral flow tests in just seconds. Discover more Play/Pause Previous Next Slide 1 Slide 2 Slide 3 The Alere Cholestech LDX® System is the leader in point of care lipid testing. Discover more Rapid point of care diagnostics plays a pivotal role in antimicrobial resistance. Learn more Discover Alere Viewpoints News and Press Contact Us Accessible, point-of-care molecular testing Alere™ q HIV-1/2 Detect assay has been awarded World Health Organization (WHO) prequalification, making it available for public sector procurement. Read more about why diagnosing HIV in infants via molecular, as opposed to antibody testing, is so critical. Find out more now The Alere™ q HIV-1/2 Detect is the first-ever molecular diagnostic that identifies HIV-1 and HIV-2 at the point of care in less than 60 minutes. Viewpoints from Alere Point-of-care diagnostics is a growing and dynamic industry helping to improve clinical and economic outcomes globally. Alere brings you a variety of expert viewpoints on new innovations, insights, and impacts that are shaping the future of diagnostics around the world. Explore All Viewpoints Innovation Reflecting on Progress in Total Analytical Error Reduction in Diagnostic Tests 9/29/2016 Insight Zika Virus: A Growing Public Health Threat 9/29/2016 Impact Fighting the Growing Threat of Antimicrobial Resistance 9/29/2016 News and Press Alere Headlines The Critical Role of Point-of-Care Testing during Respiratory Season Sept 16 2016 Taking Aim at Sepsis Aug 31 2016 "Our Priority is Access as a Company" Aug 25 2016 View all headlines Press Releases Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock Sept 14 2016 Alere Reports Second Quarter 2016 Financial Results Sept 06 2016 Alere Issues Statement Aug 26 2016 View all press releases ESICM Annual Congress October 1-5, 2016 Milan, Italy Find us at Booth #414 AARC (American Association for Respiratory Care) Congress 2016 October 15-18, 2016 San Antonio, Texas Find us at Booth #803 Contact Us Contact Sales Technical Support Investors Media Careers About Our Vision Our People Alere Stories News & Events Alere Locations Viewpoints Products & Services Cardiometabolic Infectious Disease Toxicology Other Browse by Brand Investors Annual Meetings & Reports SEC Filings & Financials Financial Releases Corporate Governance Presentations & Events Contact Information Support Contact Us Product Document Search Product Demos Laboratory Test Support Resources Medical Webinars Discover how our innovative diagnostics deliver reliable and actionable information. Alere-epoc.com AlereHIV.com Alere-i.com TestTargetTreat.com Contact Us Product Document Search Careers ©2010-2016 Alere. All rights reserved. The Alere Logo and Alere are trademarks of the Alere group of companies. All other trademarks referenced are trademarks of their respective owners. This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Alere takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage. Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. California Transparency in Supply Chains Act | Declaration for California Compliance Law